Matrix metalloproteinase mRNA expression in canine anal furunculosis lesions

Veterinary Immunology and Immunopathology

Volumn 115, Issue 1-2, 2007, Pages 68-75

  House, A K ^a   Catchpole, B ^a   Gregory, S P ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Anal furunculosis; Canine; Matrix metalloproteinase

Indexed keywords

COLLAGENASE 3; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ANUS DISEASE; ANUS FURUNCULOSIS; ARTICLE; CONTROLLED STUDY; DOG DISEASE; FEMALE; HELPER CELL; IMMUNE DYSREGULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANUS DISEASES; CELL LINE; DOG DISEASES; DOGS; FEMALE; FURUNCULOSIS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RNA, MESSENGER;

CANIS FAMILIARIS;

EID: 33845433740     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.10.018     Document Type: Article

References (42)

1. Agren M.S. Gelatinase activity during wound healing. Br. J. Dermatol. 131 (1994) 634-640
2. Aimes R.T., and Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270 (1995) 5872-5876
3. Bailey C.J., Hembry R.M., Alexander A., Irving M.H., Grant M.E., and Shuttleworth C.A. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J. Clin. Pathol. 47 (1994) 113-116
4. Barnes A., Bee A., Bell S., Gilmore W., Mee A., Morris R., and Carter S.D. Immunological and inflammatory characterisation of three canine cell lines: K1 K6 and DH82. Vet. Immunol. Immunopathol. 75 (2000) 9-25
5. Calabro A., Grappone C., Pellegrini G., Evangelista S., Tramontana M., Schuppan D., Herbst H., and Milani S. Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing. Digestion 70 (2004) 127-138
6. Day M.J., and Penhale W.J. Serum immunoglobulin A concentrations in normal and diseased dogs. Res. Vet. Sci. 45 (1988) 360-363
7. Day M.J., and Weaver B.M.Q. Pathology of surgically resected tissue from 305 cases of anal furunculosis in the dog. J. Small Anim. Pract. 33 (1992) 583-589
8. Distler J.H., Jungel A., Huber L.C., Seemayer C.A., Reich III C.F., Gay R.E., Michel B.A., Fontana A., Gay S., Pisetsky D.S., and Distler O. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2892-2897
9. Doust R., Griffiths L.G., and Sullivan M. Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs. Vet. Rec. 152 (2003) 225-229
10. Dreier R., Grassel S., Fuchs S., Schaumburger J., and Bruckner P. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp. Cell Res. 297 (2004) 303-312
11. Ellison G.W. Treatment of perianal fistulas in dogs. J. Am. Vet. Med. Assoc. 206 (1995) 1680-1682
12. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., Jewell D.P., Rachmilewitz D., Sachar D.B., Sandborn W.J., and Sutherland L.R. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis. 6 (2000) 8-15
13. Hardie R.J., Gregory S.P., Tomlin J., Sturgeon C., Lipscomb V., and Ladlow J. Cyclosporine treatment of anal furunculosis in 26 dogs. J. Small Anim. Pract. 46 (2005) 3-9
14. Harvey C.E. Perianal fistula in the dog. Vet. Rec. 91 (1972) 25-33
15. Houlton J.E. Canine anal furunculosis: a modified approach. J. Small Anim. Pract. 21 (1980) 585-593
16. House A., Gregory S.P., and Catchpole B. Expression of cytokine mRNA in canine anal furunculosis lesions. Vet. Rec. 153 (2003) 354-358
17. Jamieson P.M., Simpson J.W., Kirby B.M., and Else R.W. Association between anal furunculosis and colitis in the dog: preliminary observations. J. Small Anim. Pract. 43 (2002) 109-114
18. Johansson N., Saarialho-Kere U., Airola K., Herva R., Nissinen L., Westermarck J., Vuorio E., Heino J., and Kahari V.M. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208 (1997) 387-397
19. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases in skin. Exp. Dermatol. 6 (1997) 199-213
20. Kiili M., Cox S.W., Chen H.Y., Wahlgren J., Maisi P., Eley B.M., Salo T., and Sorsa T. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J. Clin. Periodontol. 29 (2002) 224-232
21. Killingsworth C.R., Walshaw R., Dunstan R.W., and Rosser Jr. E.J. Bacterial population and histologic changes in dogs with perianal fistula. Am. J. Vet. Res. 49 (1988) 1736-1741
22. Kirkegaard T., Hansen A., Bruun E., and Brynskov J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53 (2004) 701-709
23. Kobayashi T., Hattori S., and Shinkai H. Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm. Venereol. 83 (2003) 105-107
24. Lane J.G., and Burch D.G. The cryosurgical treatment of canine anal furunculosis. J. Small Anim. Pract. 16 (1975) 387-392
25. Mathews K.A., Ayres S.A., Tano C.A., Riley S.M., Sukhiani H.R., and Adams C. Cyclosporin treatment of perianal fistulas in dogs. Can. Vet. J. 38 (1997) 39-41
26. Netzel-Arnett S., Mitola D.J., Yamada S.S., Chrysovergis K., Holmbeck K., Birkedal-Hansen H., and Bugge T.H. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J. Biol. Chem. 277 (2002) 45154-45161
27. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., and Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72 (1995) 311-322
28. Ollivier F.J., Brooks D.E., Kallberg M.E., Komaromy A.M., Lassaline M.E., Andrew S.E., Gelatt K.N., Stevens G.R., Blalock T.D., Van Setten G.B., and Schultz G.S. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am. J. Vet. Res. 64 (2003) 1081-1087
29. Pap T., Shigeyama Y., Kuchen S., Fernihough J.K., Simmen B., Gay R.E., Billingham M., and Gay S. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 43 (2000) 1226-1232
30. Patricelli A.J., Hardie R.J., and McAnulty J.E. Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. J. Am. Vet. Med. Assoc. 220 (2002) 1009-1016
31. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45-
32. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., and Kaye P.M. Tissue cytokine responses in canine visceral leishmaniasis. J. Infect. Dis. 183 (2001) 1421-1424
33. Robins G.M., and Lane J.G. The management of anal furunculosis. J. Small Anim. Pract. 14 (1973) 333-342
34. Smeets T.J., Kraan M.C., Galjaard S., Youssef P.P., Smith M.D., and Tak P.P. Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann. Rheum. Dis. 60 (2001) 561-565
35. Stahle-Backdahl M., Sandstedt B., Bruce K., Lindahl A., Jimenez M.G., Vega J.A., and Lopez-Otin C. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76 (1997) 717-728
36. Vaalamo M., Karjalainen-Lindsberg M.L., Puolakkainen P., Kere J., and Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152 (1998) 1005-1014
37. Vaalamo M., Mattila L., Johansson N., Kariniemi A.L., Karjalainen-Lindsberg M.L., Kahari V.M., and Saarialho-Kere U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109 (1997) 96-101
38. Vasseur P.B. Results of surgical excision of perianal fistulas in dogs. J. Am. Vet. Med. Assoc. 185 (1984) 60-62
39. von Lampe B., Barthel B., Coupland S.E., Riecken E.O., and Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47 (2000) 63-73
40. Warmka J.K., Winston S.E., Zeliadt N.A., and Wattenberg E.V. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 185 (2002) 8-17
41. Wu N., Jansen E.D., and Davidson J.M. Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing. J. Invest. Dermatol. 121 (2003) 926-932
42. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., and Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59 (2000) 455-461